Narcolepsy trials in Australia
7 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
- Where
- Macquarie Park
- Age
- 18 years to 71 years
- People
- 500 worldwide
- Run by
- Takeda
See details and how to joinNCT07646678 · EU 2025-522833-68-01 - Phase 2/3Taking peopleA Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Where
- Bedford Park, Clayton, Sydney
- Age
- 18 years to 70 years
- People
- 786 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT06767683 · EU 2024-519822-18-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Where
- Macquarie Park
- Age
- 18 years to 70 years
- People
- 150 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT07455383 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Where
- Sydney
- Age
- 18 years to 70 years
- People
- 176 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT07502443 - Phase 2Taking peopleA Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
- Where
- Macquarie Park
- Age
- 18 years to 70 years
- People
- 92 worldwide
- Run by
- Takeda
See details and how to joinNCT07633301 · EU 2025-522587-33-00 - Phase 2/3Taking peopleA Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
- Where
- Glebe
- Age
- 16 years to 70 years
- People
- 500 worldwide
- Run by
- Takeda
See details and how to joinNCT05816382 · EU 2023-508462-15-00 - No phaseTaking peopleA Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia
- Where
- Macquarie Park
- Age
- 18 years and over
- People
- 30
- Run by
- University of Sydney
See details and how to joinNCT07006233